Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This commentary discusses the unmet clinical and social needs associated with hypertrophic scars and keloids. The authors critically appraise these issues within the context of contemporary clinical standards of care and social mores catalyzed by the COVID-19 pandemic.

Original publication

DOI

10.1089/rej.2021.0037

Type

Journal article

Journal

Rejuvenation res

Publication Date

08/2021

Volume

24

Pages

307 - 309

Keywords

dermatology, drug development, hypertrophic scars, keloids, regenerative medicine, COVID-19, Cicatrix, Hypertrophic, Health Services Needs and Demand, Humans, Keloid, Pandemics